May 2010 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Indoor Tanning Beds/Booths Increase Melanoma Risk
THURSDAY, May 27 (HealthDay News) -- Use of indoor tanning equipment substantially increases the risk of melanoma, with the highest risk found for people who use high-speed/intensity and high-pressure indoor tanning beds, according to a report published online May 26 in Cancer Epidemiology, Biomarkers & Prevention.
Trial Finds Topical Gel Effective for Facial Acne in Preteens
TUESDAY, May 25 (HealthDay News) -- Preteens with mild-to-moderate facial acne respond well to treatment with tretinoin microsphere gel (TMG) without serious adverse effects, according to a small study published online May 24 in Pediatrics.
Research Provides Guidance for Stage III Melanoma Follow-Up
THURSDAY, May 20 (HealthDay News) -- Stage III melanoma patients or their family members detect nearly half of first relapses -- substantially more than are detected by physicians or screening radiologic tests -- and routine physical exams beyond a certain time frame are likely to detect few first systemic relapses, according to a study in the May 20 Journal of Clinical Oncology.
Use of Imaging Technology Up in Dermatology Residencies
THURSDAY, May 20 (HealthDay News) -- In the last decade, use of dermatoscopy in U.S. dermatology residency programs has increased significantly, and there has been a nonsignificant increase in the use of total body photography (TBP), with barriers to imaging use including logistics and insufficient training, according to research published in the May issue of the Journal of the American Academy of Dermatology.
Steroids for Hemangiomas Affect Immune Function
WEDNESDAY, May 19 (HealthDay News) -- Corticosteroids used for the treatment of infantile hemangiomas are associated with reductions in lymphocyte cell numbers and changes in immune function, according to a study published online May 17 in Archives of Dermatology.
Vitamin A Analogues Not Linked to Fracture Risk
TUESDAY, May 18 (HealthDay News) -- The use of vitamin A analogues such as isotretinoin and acitretin, even at high doses, is not associated with an increased risk of fractures, according to a study published in the May issue of Archives of Dermatology.
Appearance-Focused Approach May Reduce Indoor Tanning
MONDAY, May 17 (HealthDay News) -- Among women who tan indoors and exhibit seasonal affective disorder (SAD) symptoms or pathological tanning motives, an appearance-focused skin cancer prevention intervention may help reduce indoor tanning, according to a study published in the May issue of Archives of Dermatology.
Disagreement May Be High in Melanoma Diagnoses
FRIDAY, May 14 (HealthDay News) -- Though histopathologic analysis is still the gold standard for the pathologic diagnosis of melanoma, the discordance rate in routine histopathologic interpretation of melanocytic neoplasms can be high, according to research published in the May issue of the Journal of the American Academy of Dermatology.
Treatment Found to Reduce Depression in Psoriasis
FRIDAY, May 14 (HealthDay News) -- Treating psoriasis patients with adalimumab is associated with reduced depression and improved quality of life compared to placebo, according to research published in the May issue of the Journal of the American Academy of Dermatology.
FDA Warns Consumers Against Swallowing Topical Benadryl
THURSDAY, May 13 (HealthDay News) -- The U.S. Food and Drug Administration has alerted consumers regarding potentially serious side effects associated with mistakenly swallowing Benadryl Extra Strength Itch Stopping Gel, an over-the-counter (OTC) product intended only for topical use.
New FDA Program Targets Misleading Drug Advertising
WEDNESDAY, May 12 (HealthDay News) -- The U.S. Food and Drug Administration has announced the launch of a new program to educate health care providers regarding their role in making certain that advertisements and promotions for prescription drugs are truthful and not misleading.